Doranidazole

Doranidazole

SCHEMBL7208974

O=[N+]([O-])c1nccn1CO[C@H](CO)[C@H](O)CO

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.47
LMNA P02545 1/20 0.45
THRB P10828 1/20 0.45
CYP2C19 P33261 1/20 0.45
TYMP P19971 3/20 0.41
CA12 O43570 5/20 0.40
CA1 P00915 5/20 0.40
CA2 P00918 5/20 0.40
CA9 Q16790 5/20 0.40
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
OPRK1 P41145 1/20 0.39
MGAM O43451 2/20 0.32
ALDH1A1 P00352 1/20 0.32
HTT P42858 1/20 0.32
NOS1 P29475 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Doranidazole SCHEMBL8279382 1.00 KMT2A (0.47) KMT2ALMNATHRBCYP2C19TYMP
Doranidazole SCHEMBL8279381 1.00 KMT2A (0.47) KMT2ALMNATHRBCYP2C19TYMP
Doranidazole SCHEMBL2840259 1.00 KMT2A (0.47) KMT2ALMNATHRBCYP2C19TYMP
Doranidazole SCHEMBL7201581 1.00 KMT2A (0.47) KMT2ALMNATHRBCYP2C19TYMP
SCHEMBL9237087 0.91 KMT2A (0.47) KMT2ALMNATHRBCYP2C19TYMP
SCHEMBL13627316 0.91 KMT2A (0.47) KMT2ALMNATHRBCYP2C19TYMP
SCHEMBL9975773 0.91 KMT2A (0.47) KMT2ALMNATHRBCYP2C19TYMP
SCHEMBL17706716 0.89 KMT2A (0.43) KMT2ALMNATHRBCYP2C19TYMP
SCHEMBL17706714 0.89 KMT2A (0.43) KMT2ALMNATHRBCYP2C19TYMP
SCHEMBL27791575 0.88 KMT2A (0.49) KMT2ALMNATHRBCYP2C19TYMP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0632028-B1 OPTICALLY ACTIVE 2-NITROIMIDAZOLE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND INTERMEDIATE FOR PRODUCING THE SAME POLA CHEM IND INC (JP) 2003-04-02 EP disclosed
US-5532380-A RADIOSENSITIZERS FOR CANCER THERAPY; PURE ENANTIOMORPHS POLA CHEMICAL INDUSTRIES, INC. (JP) 1996-07-02 US disclosed
EP-0632028-A1 OPTICALLY ACTIVE 2-NITROIMIDAZOLE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND INTERMEDIATE FOR PRODUCING THE SAME POLA CHEMICAL INDUSTRIES, INC. (JP) 1995-01-04 EP disclosed